|
ハギワラ ノブヒサ
Nobuhisa Hagiwara
萩原 誠久 所属 その他 その他 職種 非常勤嘱託 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study. |
| 掲載誌名 | 正式名：Journal of cardiology : Official Journal of the Japanese College of Cardiology 略 称：J Cardiol ISSNコード：0914-5087/1876-4738 |
| 掲載区分 | 国内 |
| 出版社 | Elsevier |
| 巻・号・頁 | pp.in press |
| 著者・共著者 | Sakamoto Yuki, Nishiyama Yasuhiro, Iwasaki Yu-Ki, Daida Hiroyuki, Toyoda Kazunori, Kitagawa Kazuo, Okumura Ken, Kusano Kengo, Hagiwara Nobuhisa, Fujimoto Shigeru, Miyamoto Susumu, Otsuka Toshiaki, Iguchi Yasuyuki, Kanamaru Takuya, Yamamoto Teppei, Kaburagi Jumpei, Kimura Tetsuya, Matsumoto Takuyuki, Kimura Kazumi, Shimizu Wataru, |
| 発行年月 | 2019/07 |
| 概要 | CONCLUSION:
This study will investigate the effectiveness and safety of CA and basic anticoagulation treatment with edoxaban for patients with NVAF who have suffered a recent ischemic stroke. The aim is to determine the best evidence for an optimal treatment strategy for patients with NVAF and recent stroke. |
| DOI | 10.1016/j.jjcc.2019.06.002 |
| PMID | 31337525 |